DaVita

About

DaVita is a provider focused on transforming care delivery to improve quality of life for patients globally.

Denver,Colorado,United States
10001 - max
http://www.davita.com

Highlights

Details

Last Funding Type: Post-IPO Debt
Last Funding Money Raised: $750M
Industries: Health Care
Founded date: Jan 1, 1979
Number Of Employee: 10001 - max
Operating Status: Active
Stock Symbol: nyse:DVA
Legal Name: Davita, Inc.

DaVita is a provider of kidney care in the United States, delivering dialysis services to patients with chronic kidney failure and end stage renal disease. DaVita strives to improve patients’ quality of life by innovating clinical care, and by offering integrated treatment plans, personalized care teams and convenient health-management services. As of June 30, 2012, DaVita operated or provided administrative services at 1,884 outpatient dialysis centers located in the United States, serving approximately 149,000 patients. The company also operated 19 outpatient dialysis centers located in four countries outside the United States. DaVita supports numerous programs dedicated to creating positive, sustainable change in communities around the world. The company’s leadership development initiatives and social responsibility efforts have been recognized by Fortune, Modern Healthcare, Newsweek and WorldBlu.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

2

$750M

DaVita has raised a total of $750M in funding over 2 rounds. Their latest funding was raised on Feb 24, 2021 from a Post-IPO Debt round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Feb 24, 2021	Post-IPO Debt	$750M	—	—	—	Detail
Nov 10, 1995	IPO	—	—	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

2

1

DaVita has made 2 investments. Their most recent investment was on Apr 11, 2022, when Rockwell Medical raised $15M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Apr 11, 2022 Rockwell Medical	Post-IPO Equity	$15M	Biopharma	Yes
Oct 30, 2013 CVRx	Series F	$12M	Biotechnology	—

Employee Profiles

Number of Employee Profiles

22

DaVita has 22 current employee profiles, including Executive Brannan Schell

Executive

Executive

Executive

Executive

Executive

Exits

DaVita has had 2 exits. DaVita most notable exits include CVRx , Rockwell Medical

Date	Company Name	Exit Type	Industry
Jun 29, 2021	CVRx	IPO	Biotechnology	Detail
Jan 27, 1998	Rockwell Medical	IPO	Biopharma	Detail

Acquisition

DaVita has acquired 6 organizations. Their most recent acquisition was Gambro Healthcare on Dec 7, 2004. They acquired Gambro Healthcare for 0.

Date Company Name	Industry	Acquisition Type	Price
Dec 7, 2004 Gambro Healthcare	Health Care	acquisition	—	Detail
Nov 1, 2012 HealthCare Partners	Biotechnology	—	—	Detail
May 19, 2016 Family Health Care of Central Florida	Association	acquisition	—	Detail
May 8, 2017 Purity Dialysis	Health Care	acquisition	—	Detail
Nov 28, 2017 Northwest Physicians Network	Health Care	acquisition	—	Detail